Open AccessDeletion of LysM in LysMCre Recombinase Homozygous Mice is Non-contributory in LPS-Induced Acute Lung Injury
Author(s) -
Ke-Qin Gong,
Charles W. Frevert,
Anne M. Manicone
Publication year - 2019
Publication title -
lung
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 57
eISSN - 1432-1750
pISSN - 0341-2040
DOI - 10.1007/s00408-019-00286-5
Subject(s) - gene , biology , allele , recombinase , inflammation , cre recombinase , lung , microbiology and biotechnology , immunology , medicine , genetics , recombination , transgene , genetically modified mouse
Lysozyme is an important component of the innate immune system and has roles in peptidoglycan cleavage of gram-positive organisms. Myeloid cells highly express the isoform, lysozyme M, and its promoter has been used to direct Cre recombinase expression to target deletion of floxed genes in myeloid cells. However, generation of the LysMCre mouse effectively disrupts the LysM gene, and mice homozygous for the Cre allele lack the LysM gene product. To test the contribution of LysM in sterile acute lung injury, we generated LysMCre mice homozygous for the Cre allele (+/+) or wild-type allele (-/-). These mice were challenged with LPS delivered via oropharygneal aspiration. Mice were monitored and weighed daily, and BAL cell counts, differential, protein, and cytokine levels were assessed at days 2 and 4. LysMCre+/+ and LysMCre-/- had similar weight loss and recovery, and similar inflammatory responses to LPS at days 2 and 4. These findings indicate that loss of LysM and expression of Cre recombinase are non-contributory in sterile acute lung injury.